Atlas Trials

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

Clinical trial NCT00657813 · TERMINATED

Trial details

NCT number
NCT00657813
Sponsor
Institute for Neurodegenerative Disorders
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2008-03-01
Primary completion
2008-09-30
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.